Enhance Skin Products Inc: 10-Q filed 2015-12-17

Name: Enhance Skin Products Inc: 10-Q filed 2015-12-17
Creator: Enhance Skin Products Inc
License: https://creativecommons.org/licenses/by/4.0/

What Enhance Skin Products Inc reported in its quarterly report filed 2015-12-17 (fiscal Q2 2016): 17 published measures, 44 facts as tagged in accession 0001127855-15-000488.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-12-17
Fiscal period: fiscal Q2 2016
Accession: 0001127855-15-000488 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Enhance Skin Products Inc filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-10-31	4,405	USD
At 2015-04-30	1,582	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-10-31	725,894	USD
At 2015-04-30	580,414	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-10-31	-721,489	USD
At 2015-04-30	-578,832	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-10-31	4,404	USD
At 2015-04-30	1,582	USD
At 2014-10-31	2,575	USD
At 2014-04-30	1,136	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	-192,386	USD	92
2015-05-01 to 2015-10-31	-221,832	USD	184
2014-08-01 to 2014-10-31	-32,726	USD	92
2014-05-01 to 2014-10-31	-74,578	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-05-01 to 2015-10-31	-61,472	USD	184
2014-05-01 to 2014-10-31	-31,826	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-05-01 to 2015-10-31	65,167	USD	184
2014-05-01 to 2014-10-31	33,162	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-10-31	-2,697,541	USD
At 2015-04-30	-2,476,581	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2015-08-01 to 2015-10-31	USD	92
2015-05-01 to 2015-10-31	USD	184
2014-08-01 to 2014-10-31	USD	92
2014-05-01 to 2014-10-31	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-10-31	4,404	USD
At 2015-04-30	1,582	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	30,596	USD	92
2015-05-01 to 2015-10-31	37,739	USD	184
2014-08-01 to 2014-10-31	11,862	USD	92
2014-05-01 to 2014-10-31	33,162	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-10-31	725,894	USD
At 2015-04-30	580,414	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2015-10-31	1	USD
At 2015-04-30	0	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-10-31	104,955,382	shares
At 2015-04-30	101,017,881	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-10-31	1,872,910	USD
At 2015-04-30	1,797,671	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-10-31	-1,812	USD
At 2015-04-30	-939	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	7,352	USD	92
2015-05-01 to 2015-10-31	11,639	USD	184
2014-08-01 to 2014-10-31	8,449	USD	92
2014-05-01 to 2014-10-31	12,062	USD	184

Inspect the source

Entity: Enhance Skin Products Inc / CIK 0001395400
Captured: 2026-09-23 02:52 UTC
SEC response SHA-256: fff314d957d2a5940255b53225a3e1f542672b71939f6a26169d71841b05f4a6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001395400.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))